Pfizer Inc (PFE)

$26.78 +1.01 (3.92%)
Market Cap 146.52B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.33
Forward PE 8.99
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 83,025,800
Avg Vol 49,743,188
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 88%
Beta 0.47
Analysts Sell
Price Target $28.43

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Feb. 5 at 12:29 AM
$PFE some people are hiding in this twits. They talk all day .act like they care if this goes up .but really are just a seed .to plant in your head confusions..do yourself a favor don't stay on twits to find what to invest in .do your homework don't be influenced by twit heads that have nothing better to do all day but post .I'm whith Pfizer for a break from trading .a place to park some of my money. And make some good dividends. I sstold some of my pfe .to put in khc stock .it also pays an equal amount of dividend .the point is .if they talk all day on twits .question it ..I'm doing good with only my safe plays .this is 1 of them .good luck people ...
0 · Reply
Tiger65
Tiger65 Feb. 4 at 10:39 PM
$PFE it’s getting more interesting now. I’ve used yesterday‘s dip to sell my hedge and buy more shares. Congrats to all buyers. To help the stock, buy the dips and/or buy in the money calls the broker has to acquire for hedging. Good luck, lol.
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 4 at 9:54 PM
$PFE tf is this AH lol
2 · Reply
TrevorCoryCapital
TrevorCoryCapital Feb. 4 at 9:32 PM
$PFE 24.50
0 · Reply
drpgadan59
drpgadan59 Feb. 4 at 9:12 PM
$PFE let’s go $27.50 ah
1 · Reply
CuriouslyPanda
CuriouslyPanda Feb. 4 at 8:42 PM
$PFE I said this a week ago...up +25% on these LEAPS just getting warmed up 👨‍🚒🔥🚒
0 · Reply
SawyerMarlow
SawyerMarlow Feb. 4 at 8:34 PM
$PFE If volume expands, breakout above resistance could fuel trend continuation
0 · Reply
SilverTrader47
SilverTrader47 Feb. 4 at 8:34 PM
$PFE $NVO Pfizer needs this drug, known as PF’3944, to work. The company spent $10 billion to buy its original developer Metsera after a contentious bidding war with Novo Nordisk. And that came after multiple failed attempts to develop obesity drugs in-house. Two were scrapped because of safety concerns. https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/
0 · Reply
Typecheck
Typecheck Feb. 4 at 8:27 PM
$PFE not complaining but why?
0 · Reply
robolo
robolo Feb. 4 at 8:23 PM
$PFE I can’t believe this thing saved my portfolio today…
0 · Reply
Latest News on PFE
Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 1 day ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 1 day ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 1 day ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 1 day ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 1 day ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 1 day ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 1 day ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 1 day ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 1 day ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 1 day ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 1 day ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 1 day ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 7:02 AM EST - 1 day ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:57 AM EST - 1 day ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:50 AM EST - 1 day ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 1 day ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Feb 3, 2026, 6:45 AM EST - 1 day ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Feb 3, 2026, 6:40 AM EST - 1 day ago

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

Feb 2, 2026, 8:42 AM EST - 2 days ago

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

SNY

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Feb 2, 2026, 1:01 AM EST - 2 days ago

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

Jan 31, 2026, 3:47 AM EST - 4 days ago

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

BBY CAG EQR FRT KEY LYB MAA

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 10:31 AM EST - 5 days ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Why Dividend Stocks Are Essential For What Comes Next

Jan 30, 2026, 7:30 AM EST - 5 days ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Pfizer: A High-Yield Pharma At A Turning Point

Jan 29, 2026, 9:00 AM EST - 6 days ago

Pfizer: A High-Yield Pharma At A Turning Point

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Jan 27, 2026, 4:52 PM EST - 8 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

ABBV LLY

Pfizer vs. Merck Stock And JNJ

Jan 27, 2026, 7:40 AM EST - 8 days ago

Pfizer vs. Merck Stock And JNJ

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Jan 27, 2026, 6:02 AM EST - 8 days ago

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

Jan 23, 2026, 10:33 AM EST - 12 days ago

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

Jan 23, 2026, 9:54 AM EST - 12 days ago

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

AGNC AGNCP ARLP ECC EFC ET FBRT

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:34 PM EST - 15 days ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

Jan 20, 2026, 12:18 PM EST - 15 days ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 15 days ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 20, 2026, 2:19 AM EST - 15 days ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

Jan 19, 2026, 8:10 PM EST - 16 days ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 16 days ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

Pfizer: Rebound Has Just Started

Jan 16, 2026, 1:08 PM EST - 19 days ago

Pfizer: Rebound Has Just Started

Pfizer: The Most Intriguing Value Play Of 2026

Jan 15, 2026, 8:58 AM EST - 20 days ago

Pfizer: The Most Intriguing Value Play Of 2026

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Jan 13, 2026, 6:11 AM EST - 22 days ago

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Jan 12, 2026, 6:43 PM EST - 23 days ago

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:16 PM EST - 23 days ago

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Jan 10, 2026, 10:00 AM EST - 25 days ago

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Healthy Returns: What to expect from pharma at the JPM conference

Jan 9, 2026, 12:57 PM EST - 26 days ago

Healthy Returns: What to expect from pharma at the JPM conference

AMGN AZN BMY LLY MRK NVO

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Jan 8, 2026, 8:00 AM EST - 27 days ago

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Jan 7, 2026, 2:16 PM EST - 4 weeks ago

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 4 weeks ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 4 weeks ago

America's new vaccine doctrine for children replaces data with dogma

MRNA

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Jan 6, 2026, 7:30 AM EST - 4 weeks ago

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jan 5, 2026, 10:00 AM EST - 4 weeks ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 4 weeks ago

Pfizer 2026: The Reset Year

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

Dec 31, 2025, 8:37 AM EST - 5 weeks ago

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

AGNC PFLT

Willieberich
Willieberich Feb. 5 at 12:29 AM
$PFE some people are hiding in this twits. They talk all day .act like they care if this goes up .but really are just a seed .to plant in your head confusions..do yourself a favor don't stay on twits to find what to invest in .do your homework don't be influenced by twit heads that have nothing better to do all day but post .I'm whith Pfizer for a break from trading .a place to park some of my money. And make some good dividends. I sstold some of my pfe .to put in khc stock .it also pays an equal amount of dividend .the point is .if they talk all day on twits .question it ..I'm doing good with only my safe plays .this is 1 of them .good luck people ...
0 · Reply
Tiger65
Tiger65 Feb. 4 at 10:39 PM
$PFE it’s getting more interesting now. I’ve used yesterday‘s dip to sell my hedge and buy more shares. Congrats to all buyers. To help the stock, buy the dips and/or buy in the money calls the broker has to acquire for hedging. Good luck, lol.
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 4 at 9:54 PM
$PFE tf is this AH lol
2 · Reply
TrevorCoryCapital
TrevorCoryCapital Feb. 4 at 9:32 PM
$PFE 24.50
0 · Reply
drpgadan59
drpgadan59 Feb. 4 at 9:12 PM
$PFE let’s go $27.50 ah
1 · Reply
CuriouslyPanda
CuriouslyPanda Feb. 4 at 8:42 PM
$PFE I said this a week ago...up +25% on these LEAPS just getting warmed up 👨‍🚒🔥🚒
0 · Reply
SawyerMarlow
SawyerMarlow Feb. 4 at 8:34 PM
$PFE If volume expands, breakout above resistance could fuel trend continuation
0 · Reply
SilverTrader47
SilverTrader47 Feb. 4 at 8:34 PM
$PFE $NVO Pfizer needs this drug, known as PF’3944, to work. The company spent $10 billion to buy its original developer Metsera after a contentious bidding war with Novo Nordisk. And that came after multiple failed attempts to develop obesity drugs in-house. Two were scrapped because of safety concerns. https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/
0 · Reply
Typecheck
Typecheck Feb. 4 at 8:27 PM
$PFE not complaining but why?
0 · Reply
robolo
robolo Feb. 4 at 8:23 PM
$PFE I can’t believe this thing saved my portfolio today…
0 · Reply
Quantumup
Quantumup Feb. 4 at 7:53 PM
Canaccord Genuity⬆️ $CMPX's PT to $13 from $10, reiterated at Buy and said, We see upside to $13 and downside to $4 on upcoming Phase 2/3 data for tovecimig + paclitaxel expected end of 1Q26. $BMY $TEVA $SNY $PFE AMGN We see a low bar vs paclitaxel monotherapy, and note Compass demonstrated a statistically significant benefit for response rate. We also believe safety is manageable, with Grade 3+ neutropenia likely lower vs Phase 2. We also benchmarked Progression Free Survival and Overall Survival (OS) against standard of care FOLFOX.
0 · Reply
TheWayISeeIt
TheWayISeeIt Feb. 4 at 7:49 PM
$NWBO 😂😂😂 $MSFT $PFE $MRNA
1 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Feb. 4 at 7:39 PM
$PFE my break even is $28 by Jan 2028 lol. I expect you guys to pump this bitch to the 80s by then.
0 · Reply
Quantumup
Quantumup Feb. 4 at 7:09 PM
Wolfe Research said in its $CELC (Outperform; PT $110) note: PersevERAing through an External Catalyst $RHHBY $RLAY $AZN $PFE NVS LLY Wolfe Research additionally said: We think investors should be careful when extrapolating giredestrant's prior success to persevERA as it is a more difficult trial to beat, even after acknowledging that giredestrant is a good drug. We'd be buyers of CELC on any weakness related to the external catalyst.
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 4 at 6:19 PM
$PFE She’s obsessed with 26.66 lol
0 · Reply
Congostockchat
Congostockchat Feb. 4 at 5:58 PM
$PFE looking much better today! earnings report was very good.
0 · Reply
Mister_Wonderful
Mister_Wonderful Feb. 4 at 5:37 PM
$PFE The only green today. Love it!
0 · Reply
thebrockettman
thebrockettman Feb. 4 at 5:36 PM
$PFE I woke up today expecting more pain. Pleasantly surprised! Let's hope we finish out the week strong 🤞🏻
0 · Reply
Cedenmo
Cedenmo Feb. 4 at 5:33 PM
$BMY $MRK $PFE Fantastic movement for my “Big 3.”
0 · Reply
CreamOfTheCrocs
CreamOfTheCrocs Feb. 4 at 5:30 PM
$PFE getting longer than a bowl of oatmeal
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 4 at 5:16 PM
$PFE bruh
1 · Reply
randallb
randallb Feb. 4 at 5:03 PM
$PFE PLX - hod institutions adding read news.. Buyout candidate Lilly/PFE ? Up 5 days in a row, soon 3 - 6 months.. PLX real deal guys..
0 · Reply